What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that ...

After the emotional shock of a breast cancer recurrence, Teah decided to seek care – and proton therapy – at Fred Hutch ...

During his 36-year career at Cancer Center, Michael Emerman, PhD, made fundamental discoveries about HIV, the retrovirus that ...

A new AI application that is part of an 'ambient listening' pilot program is helping physicians at Fred Hutch Cancer Center ...

Thanks to generous support and partnership from Alexandria Real Estate Equities, Inc., Fred Hutch has a new, state-of-the-art learning laboratory where high school and college students who participate ...

Fred Hutch and MSK researchers showed that tumors driven by hiccups in RNA processing can't hid from the immune system. In work published in Cell, the team showed they could isolate T cells that ...

A study by researchers at Fred Hutch Cancer Center published in Nature revises the standard story about transcription factors binding close to the genes they regulate. That is true only for a small ...

A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients have been told that multiple myeloma is treatable but not curable. Yet data ...

Fred Hutch virologist Keith Jerome, MD, PhD, and evolutionary biologist Jesse Bloom, PhD, were recently elected to the 2025 class of fellows of the American Academy of Microbiology.